Event Recordings
Day 1 | Day 2
Session I: Fireside Chat with Robert Califf, MD, FDA Commissioner
Moderator: Robert Harrington, MD
Robert Califf, MD, MACC
FDA Commissioner
Session II: Drug Development I
Moderator: Sandra Horning, MD
Human Genetics & Drug Discovery
Andrew Plump, MD, PhD
President, R&D, Takeda Pharmaceutical Company
Leading Design for Breakthrough Therapies and Vaccines
Mikael Dolsten, MD, PhD
CSO and President, Worldwide Research, Development and Medical, Pfizer
From Data to Insights to Impact
How Data Science is Central to Discovering and Developing Medicines
Najat Khan, PhD
Chief Data Science Officer & Global Head, Strategy and Operations, R&D, Janssen Pharmaceutical Companies of Johnson & Johnson
Enabling drug discovery innovation through a global open access platform
Steve Yang, PhD
Co-CEO, WuXi AppTec
Session II: Panel Discussion
Session III: Funding Drug Development
Session III: Panel Discussion
Moderator: Mathai Mammen, MD, PhD
Speakers:
Jim Tananbaum, MD
CEO and Founder, Foresite Capital Management, LLC
Monica Beam, PhD
Senior Vice President, Science & Technology, Alexandria Real Estate Equities, Inc/Alexandria Venture Investments
Lip-Bu Tan, MBA
Managing Partner, Walden Catalyst
Joshua Bleharski, PhD
Managing Director, Healthcare Investment Banking, J.P. Morgan
Session IV: Presentation of Lifetime Achievement Award
Moderator: Levi Garraway, MD, PhD
Imatinib as a Paradigm of Targeted Cancer Therapies
Brian Druker, MD
Director, OHSU Knight Cancer Institute
Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine, OHSU
Session V: Drug Development II
Moderator: Helen Blau, PhD
What Could be Better Than Disease Prevention?
Hal Barron, MD
CEO, Altos Labs
Using Big Data to Develop Therapeutic Signatures of Response for Cancer
George Sledge, Jr., MD
Executive Vice President and CMO, Caris Life Sciences
Reimagining Pharmacovigilance
Aida Habtezion, MD
CMO and Head of Worldwide Medical & Safety, Pfizer
Drug Discovery in the Modern Era
Mathai Mammen, MD, PhD
CEO Designate, FogPharma; Former Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
Session V: Panel Discussion
Session VI: CEO Fireside Chat
Moderator: Lloyd Minor, MD
Speakers:
Alexander Hardy, MBA
CEO, Genentech
Robert Bradway, MBA
Chairman and CEO, Amgen
Michelle McMurry-Heath, MD, PhD
Former President and CEO, Biotechnology Innovation Organization